Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

Studies Show ABT-263 and ABT-869 to be Promising in Targeting Cancer Cells'

Underlying Mechanisms

ABBOTT PARK, Ill., May 15 /PRNewswire-FirstCall/ -- Abbott scientists will highlight the latest clinical trial data of several investigative compounds in the company's oncology pipeline at this year's American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled for May 30 in Chicago. The presentations include ABT-263, a Bcl-2 family protein antagonist, and ABT-869, an oral small molecule that provides simultaneously potent and specific inhibition of the VEGFR and PDGFR families. Both compounds were discovered by Abbott scientists and are being co-developed by Abbott and Genentech. The company's meeting abstracts are available online today at http://www.asco.org.

By targeting a key survival mechanism of cancer cells, Abbott scientists identified ABT-263 as a potent inhibitor of Bcl-2 family proteins. The Bcl-2 family proteins regulate apoptosis (programmed cell death), the natural process by which damaged or unwanted cells die and are cleared from the body. When this process is defective, damaged cells can continue to divide, leading to the formation and growth of tumors. Preclinical studies showed promising activity against chronic lymphocytic leukemia (CLL), lymphomas and small cell lung cancer -- Phase I/II trials are currently underway in these diseases.

Additionally, Abbott scientists are targeting another vital characteristic of cancer cells with ABT-869. In early studies, data have shown that ABT-869 inhibits a distinct set of kinases that are involved in angiogenesis, a process by which tumors gain access to new blood vessels. Inhibition of these kinases may suppress tumor growth by cutting off tumor blood supply. ABT-869 is currently being tested against several tumor types in Phase II clinical trials.

"Researchers from around the world have requ
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 More than 200 ... to a federal litigation that continues to progress in ... Liebhard LLP reports. , A federal Case List ... over the widely-used cholesterol medication by plaintiffs who developed ... to claims, Pfizer Inc. failed to adequately warn patients ...
(Date:9/1/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 (HealthDay ... American aid workers successfully cured a group of monkeys infected ... The drug, ZMapp, prompted recovery in all 18 monkeys who ... five days after infection. ZMapp even cured monkeys with ... away from death, said study senior author Gary Kobinger, chief ...
(Date:9/1/2014)... September 01, 2014 As well as ... Derek is currently pursuing counselor certification in Louisiana. ... through the CPI training program as well as the ... have grown both personally and professionally. I am ... am competently able to do so. As a ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Bioinformatics ... organize and analyze biological and genetic data. A ... activity of developing software tools to generate and ... be confused with biological computation. While bioinformatics simply ... of biology can its related concepts, biological computation ...
(Date:9/1/2014)... NJ (PRWEB) September 01, 2014 Registration is ... The Warriors® 5K and 1-Mile Race to be held on ... The Plaza Court Yard at Harmon Meadow in Secaucus, New ... The Warriors®, a national nonprofit dedicated to restoring a sense ... our service members and our military families. , General registration ...
Breaking Medicine News(10 mins):Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 2Health News:South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2
... PHOENIX, July 1 The boards of ... Long Term Care announced today the appointment ... operations, effective,immediately. In Arizona, SCAN offers a ... also provides long-term care services to,individuals enrolled ...
... & Ellis Healthcare,REIT, Inc. today announced the acquisition ... properties comprising 20 buildings,located throughout Indianapolis., Medical ... of,gross leaseable area. The portfolio is 91 percent ... which has occupancy in nine of the 13,properties ...
... processing in brain, affect development, researcher says , , TUESDAY, ... intensive care must undergo numerous painful interventions, not enough ... suggests. , Of the 42,413 painful procedures included in ... medications, and just 18.2 percent received non-pharmacological pain therapy. ...
... by University of Michigan scientists suggest that people who experience ... different forms of the disease that require different kinds of ... point to a time when doctors will be able to ... help MS patients, using available drugs and new ones in ...
... for better treatments of certain malignancies , , TUESDAY, July 1 ... a kind of dimmer switch to stop a "cancer signal" ... don,t represent a cure, and no one knows if they ... research does clear a pathway for scientists to follow as ...
... Insurance Services,Inc., has been sold to Assurance Investment Partners ... Shield in Kentucky, Arison has six,offices across Kentucky and ... individuals., The company will continue to operate under ... employees will be employed by AIP. Paul,Anderson, who served ...
Cached Medicine News:Health News:SCAN Health Plan Arizona and SCAN Long Term Care Appoints Thomas Lescault President of Arizona Operations 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 2Health News:Grubb & Ellis Healthcare REIT Acquires Medical Portfolio 3 in Indianapolis 3Health News:Newborns in Intensive Care Often Exposed to Pain 2Health News:Newborns in Intensive Care Often Exposed to Pain 3Health News:Best treatment for MS may depend on disease subtype 2Health News:Best treatment for MS may depend on disease subtype 3Health News:Scientists Find Way to Dim Cancer Switch 2Health News:Assurance Investment Partners Purchases Arison Insurance Services from Anthem Blue Cross and Blue Shield 2
(Date:8/29/2014)... 29, 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the ... turnkey support services for the lawfully organized cannabis ... and approved the Company,s name and symbol change ... will be known as Chuma Holdings, Inc. ... a merger with the Company,s wholly-owned subsidiary, Chuma ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- SAM Medical Products ... for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that it has ... address a potential issue with a clip used ... Axilla application of the SAM Junctional Tourniquet (SJT).  ...
(Date:8/29/2014)... 29, 2014   Mast Therapeutics, Inc. ... today that Santosh Vetticaden, Chief Medical Officer and ... for personal reasons, in mid-September.  Edwin L. ... Aires Pharmaceuticals, which Mast acquired earlier this year, ... Company,s interim Chief Medical Officer.  Dr. Parsley previously ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... 2011 Boston Scientific Corporation (NYSE: BSX ... the First Circuit has affirmed the dismissal of a ... Company,s TAXUS® Express2 Paclitaxel-Eluting Coronary Stent System in 2004. ... Public Employees, Retirement System, had previously been dismissed by ...
... 2011 CareFusion Corp. (NYSE: CFN ), a ... quarter and fiscal year ended June 30, 2011. ... margin expansion and the benefit of strong spending controls drove ... quarter and for the year," said Kieran Gallahue, chairman and ...
Cached Medicine Technology:Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 2Boston Scientific Announces Favorable Court Ruling Dismissing Securities Fraud Case 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 2CareFusion Reports Fourth Quarter and Fiscal 2011 Results 3CareFusion Reports Fourth Quarter and Fiscal 2011 Results 4CareFusion Reports Fourth Quarter and Fiscal 2011 Results 5CareFusion Reports Fourth Quarter and Fiscal 2011 Results 6CareFusion Reports Fourth Quarter and Fiscal 2011 Results 7CareFusion Reports Fourth Quarter and Fiscal 2011 Results 8CareFusion Reports Fourth Quarter and Fiscal 2011 Results 9CareFusion Reports Fourth Quarter and Fiscal 2011 Results 10CareFusion Reports Fourth Quarter and Fiscal 2011 Results 11CareFusion Reports Fourth Quarter and Fiscal 2011 Results 12CareFusion Reports Fourth Quarter and Fiscal 2011 Results 13CareFusion Reports Fourth Quarter and Fiscal 2011 Results 14CareFusion Reports Fourth Quarter and Fiscal 2011 Results 15
... are built to deliver maximum ... The systems have the capacity ... in todays environment. Plus, ... and maximize user-friendliness, the UniCel ...
... is a unique double loaded anchor perfect for ... Poly-L Lactic Acid (PLLA) and comes in two ... the suture ends for open repairs, and can ... tip inserter allows insertion with minimal procedural steps ...
... The E-Z Tac™ implantThe USS Sports Medicine™ E-Z ... to attach soft tissue to bone. The resorbable ... in the bone and is used to reattach ... made of a resorbable copolymer, a polyester derivative ...
Umbrella Cancellous Harpoon...
Medicine Products: